NCT02796105已完成4 期
Evaluation of Efficacy and Safety of Medroxiprogesterone Acetate (Progevera 10 mg®) Versus GnRh Antagonist (Orgalutran®) in Ovarian Stimulation Cycles of Oocyte Donors
Fundació Privada Eugin1 个研究点 分布在 1 个国家目标入组 232 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 232
- 试验地点
- 1
- 主要终点
- donor ovarian response
研究概览
简要总结
Evaluation of efficacy and safety of medroxiprogesterone acetate (Progevera 10 mg®) versus GnRh antagonist (Orgalutran®) in ovarian stimulation cycles of oocyte donors
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 35 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Oocyte donors included in the oocyte donation program of Clinica EUGIN.
- •1st oocyte donation cycle at Clínica EUGIN.
排除标准
- •Polycistic Ovarian syndrome (PCOs).
- •Estradiol levels on day 2 of menstrual cycle >70 pg/ml.
- •Hormone treatments up to 3 months before the oocyte donation cycle.
- •Medical contraindication to the treatments used in the study
研究组 & 干预措施
Orgalutran
Active Comparator
Orgalutran 0.25 mg
干预措施: Orgalutran (Drug)
Progevera
Experimental
Progevera 10 mg
干预措施: Progevera (Drug)
结局指标
主要结局
donor ovarian response
时间窗: 1 month
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Evaluation of efficacy and safety of medroxiprogesterone acetate (Progevera 10 mg®) versus GnRh antagonist (Orgalutran®) in ovarian stimulation cycles of oocyte donorsInfertilityEUCTR2015-004328-73-ESFundació Privada EUGIn
招募中
3 期
Comparison of the effects of medroxyprogestron and megestrol on vasomotor symptom in menopause womeIRCT20210412050945N1Karaj University of Medical Sciences80
招募中
1 期
Comparison of the effect of medroxyprogesterone acetate and black seed extract on the symptoms of polycystic ovary syndrome in adolescent girlsPolycystic ovary syndrome.Polycystic ovarian syndromeE28.2IRCT20221017056209N1Gonabad University of Medical Sciences116
已完成
3 期
S9630, Medroxyprogesterone in Treating Women With Breast CancerEndometrial CancerBreast CancerNCT00002920SWOG Cancer Research Network313
进行中（未招募）
1 期
sefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors which are undergoing controlled ovarian stimulation (COS)EUCTR2017-002341-30-ESINSTITUTO VALENCIANO DE INFERTILIDAD (IVI)318